Journals / Haseki Tıp Bülteni / 2011 / Cilt: 49 - Sayı: 3

Malignant struma ovarii in a postmenopausal asymptomatic woman: A case report

Postmenopozal asemptomatik kadında malign struma ovari: Olgu sunumu

Pages
117–119
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Surgical staging should be included in the treatment, like in the other germ cell ovarian tumors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Struma ovarii is an ovarian tumor that consists predominantly thyroid tissue and accounts for only 2% of all mature teratomas.
📊
Key Findings & Data:It is usually a benign condition - malignant transformation has been reported to occur in about 5% of all struma ovarii cases.
💡
Conclusion & Impact:Surgical staging should be included in the treatment, like in the other germ cell ovarian tumors.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Struma ovarii is an ovarian tumor that consists predominantly thyroid tissue and accounts for only 2% of all mature teratomas. It is usually a benign condition - malignant transformation has been reported to occur in about 5% of all struma ovarii cases. Case: A 58-year-old postmenopausal woman attended our outpatient clinic for her annual gynecologic exam, on which a palpable ovary was incidentally found. Ultrasound and magnetic resonance imaging work-up showed two-centimeter solid mass on the right ovary. Laparoscopic salpingo-oophorectomy was performed; the histology report revealed a focus of thyroid papillary carcinoma in a struma ovarii. The patient underwent surgical staging procedure according to the ovarian cancer guideline. The tumor was in stage 1 A, thus, no further treatment was indicated apart from follow-up. Conclusion: Malignant struma ovarii is a rare neoplasm of the ovary. Surgical staging should be included in the treatment, like in the other germ cell ovarian tumors.

Özet

Giriş: Struma ovari; tüm matür teratomlarının %2'sini oluşturur ve ovaryen tümörde baskın hücre tipinin tiroid dokusu olmasıyla karakterizedir. Genellikle benign bir tümör davranışı sergileyen struma ovari, %5-10 oranında malign dönüşüme uğrayabilir. Olgu: Yıllık jinekolojik muayene nedeniyle polikliniğimize başvuran postmenopozal 58 yaşında bayan hastada palpabl sağ over saptanması üzerine yapılan ultrasonografi (US) ve manyetik rezonans görüntülemede (MR) sağ överde 2 cm'lik solid kitle tespit edildi. Laparoskopik salpingoooferektomi yapılan hastaya histopatolojik olarak struma ovari zemininde tiroid papiller karsinom odağı tanısı konuldu. Olguya over kanseri tedavi prensiplerine göre ikinci seansta cerrahi evreleme yapılmış olup evre 1A tümör olarak evrelen-mesi üzerine ek tedaviye gerek duyulmadı. Sonuç: Malign struma ovari, överin nadir görülen bir neo-plazmıdır. Tedaviye diğer germ tümörlerinde olduğu gibi cerrahi evreleme eklenmelidir.

🔖

Cite This Article

GÖKSEDEF, B. P., GÖRGEN, H., BARAN, Ş. Y., APİ, M., BAKIR, S., ÇETİN, A. (2011). Malignant struma ovarii in a postmenopausal asymptomatic woman: A case report. Haseki Tıp Bülteni, Cilt: 49 - Sayı: 3, 117–119. https://ajindex.com/articles/267993

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Berghella V, Ngadiman S, Rosenberg H, Hoda S, Zuna RE. Malignant struma ovarii. A case report and review of the literature. Gynecol Obstet Invest 1997;42:68-72
  2. Kabukcuoglu F Baksu A, Yilmaz B, Aktumen A, Evren I. Malignant struma ovarii. Pathol Oncol Res 2002;8:145-7
  3. Rosenblum N, LİVolsi V, Edmonds R Mikuta J. Malignant struma ovarii. Gynecol Oncol 1989;32:224-7
  4. Makani S, Kim W, Gaba AR. Struma Ovarii with a focus of papillary thyroid cancer: a case report and review of the literature. Gynecol Oncol 2004;94:835-9
  5. Matsuda K, Maehama T, Kanazawa K. Malignant struma ovarii with thyrotoxicosis. Gynecol Oncol 2001;82:575-7
  6. Çelik H, Ozercan R, Gurates B, Kavak B, Kavak E, Pala S. Benign ve malign struma ovarii: İki olgunun sunumu ve literatürün gözden geçirilmesi. Turkish J Gynecol Oncol 2005; 8: 32-6
  7. Yassa L, Sadow P Marqusee R Malignant struma ovarii. Endocrinol Metabolism 2008;8:469-72
  8. Zalel Y, Seidman DS, Oren M, et al. Sonographic and clinical characteristics of struma ovarii. Ultrasound Med 2000;19:857-61
  9. Yoo SC, Chang KH, Lyu MO, Chang SJ, Ryu HS, Kim HS. Clinical characteristics of struma ovarii. J Gynecol Oncol 2008;19:135-8
  10. Volpi E, Ferrero A, Nasi PG, Sismondi R Malignant struma ovarii: a case report of laparoscopic management. Gynecol Oncol '2003;90:191t4
  11. Devaney K, Snyder R, Norris HJ, Tavassoli FA. Related articles, proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol 1993;2:33343
  12. Makhija F? Rameshkumar K, Nirmala V. Histologic spectrum of struma ovarii. Indian J Cancer 2000;37:79-84
  13. Pazaitou-Panayiotou K, Mygdakos N, Boglou K, Kiziridou A, Chrisoulidou A, Destouni C. The Immunocytochemistry Is a Valuable Tool in the Diagnosis of Papillary Thyroid Cancer in FN As Using Liquid-Based Cytology. J Oncol 2010;2010:963926
  14. Boutross-Tadross O, Saleh R, Asa SL. Follicular variant papillary thyroid carcinoma arising in struma ovarii. Endocr Pathol 2007;18:182-6
  15. Hatami M, Breining D, Owers RL, Del Priore G, Goldberg GL. Malignant struma ovarii-a case report and review of the literature. Gynecol Obstet Invest 2008;65:104-7
  16. Marcy PY Thariat J, Benisvy D, Azuar P Lethal, malignant, metastatic struma ovarii. Thyroid 2010;20:1037-40 17. Kouraklis G, Safioleas M, Glinavou A, Xipolitas N. Papachristodoulou A and Karatzas G, Struma ovarii: report of two cases and clinical review Eur J Surg 2001;167:470-1
  17. Robboy SJ, Shaco-Levy R,